Niagen Bioscience, Inc.
NAGE
$6.76
$0.223.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.51M | 32.25M | 27.73M | 27.41M | 27.17M |
| Total Receivables | 8.67M | 8.00M | 8.72M | 7.50M | 5.23M |
| Inventory | 9.19M | 10.54M | 11.51M | 12.50M | 14.53M |
| Prepaid Expenses | 1.58M | 1.20M | 1.19M | 1.41M | 2.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 152.00K | 152.00K | 152.00K | 152.00K | 152.00K |
| Total Current Assets | 64.10M | 52.13M | 49.30M | 48.98M | 49.53M |
|
|
|||||
| Total Current Assets | 64.10M | 52.13M | 49.30M | 48.98M | 49.53M |
| Net Property, Plant & Equipment | 3.45M | 3.62M | 3.90M | 4.23M | 4.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 359.00K | 397.00K | 435.00K | 472.00K | 510.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 368.00K | 374.00K | 394.00K | 405.00K | 383.00K |
| Total Assets | 68.28M | 56.52M | 54.04M | 54.08M | 54.96M |
|
|
|||||
| Total Accounts Payable | 8.53M | 6.90M | 8.11M | 7.90M | 10.23M |
| Total Accrued Expenses | 7.82M | 9.59M | 8.62M | 10.47M | 9.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 994.00K | 1.02M | 985.00K | 861.00K | 702.00K |
| Total Finance Division Other Current Liabilities | 611.00K | 184.00K | 156.00K | 227.00K | 195.00K |
| Total Other Current Liabilities | 611.00K | 184.00K | 156.00K | 227.00K | 195.00K |
| Total Current Liabilities | 17.95M | 17.70M | 17.87M | 19.45M | 20.62M |
|
|
|||||
| Total Current Liabilities | 17.95M | 17.70M | 17.87M | 19.45M | 20.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.66M | 1.88M | 2.14M | 2.37M | 2.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.58M | 2.58M | 3.31M | 3.31M | 3.31M |
| Total Liabilities | 22.18M | 22.15M | 23.32M | 25.13M | 26.51M |
|
|
|||||
| Common Stock & APIC | 228.01M | 223.47M | 221.69M | 219.90M | 218.92M |
| Retained Earnings | -181.91M | -189.09M | -190.97M | -190.95M | -190.46M |
| Treasury Stock & Other | -4.00K | -7.00K | -2.00K | -1.00K | -4.00K |
| Total Common Equity | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M |
|
|
|||||